Press

​2020

· BBC News

"Coronavirus: cómo son las 6 vacunas contra el virus que ya se están probando en humanos y qué países están ganando la carrera" (Spanish only)

Felipe Tapia discusses the challenges on the global manufacturing of a coronavirus vaccine.

​

· Investieren in Sachsen-Anhalt

"ContiVir: Zwei neue Technologien für die Herstellung und Aufreinigung von viralen Vektoren werden kombiniert" (German only) 

Dr. Pavel Marichal and Dr. Felipe Tapia are granted €1.1 Million to focus on the development of a continuous manufacturing platform for commercially relevant viral gene therapy vectors and vaccines.

​

· Max-Planck-Institute for Dynamics of Complex Technical Systems

"Scientists of the Bioprocess Engineering group receive a €1.1 Million Startup Grant to Advance Gene Therapy Manufacturing"

Dr. Pavel Marichal and Dr. Felipe Tapia are granted €1.1 Million to focus on the development of a continuous manufacturing platform for commercially relevant viral gene therapy vectors and vaccines.

​

· Nature.com

"If a coronavirus vaccine arrives, can the world make enough?"

Felipe Tapia comments on the production of a viral coronavirus vaccine.

​

· Cell & Gene Therapy Insights

"Suspension systems in continuous viral vector production processes"

Felipe Tapia discusses the different options for continuous culture of suspension cells for the production of virus particles.

​

2019

· Genetic Engineering & Biotechnology news

"Biopharma Keeps Shifting the Steel–Plastic Balance"

Pavel Marichal discusses the advantages of single-use systems over traditional steel technologies.

​

​

• 2020

  • Nasdaq: "FDA Expects Explosion in Gene Therapy Treatments, Updates Review Policy"

  • Biopharma Reporter: "Yposkesi doubles manufacturing footprint to meet AAVs growing demand"

  • BBC News: "Gene Therapy to halt rare for of sight loss"

• 2019

  • The Guardian: "$2.1m Novartis gene therapy to become world's most expensive drug"

• 2017

  • The New York Times: "Gene Therapy Hits a Peculiar Roadblock: A Virus Shortage"

  • ​U.S Food and Drug Administration: "Modernizing the Way Drugs Are Made: A Transition to Continuous Manufacturing"

• 2016

  • ​American Pharmaceutical Review: "Achieving Large-Scale Cell and Gene Therapy Manufacturing"

  • ​FiercePharma: "FDA urges companies to get on board with continuous manufacturing"